โŒ

Normal view

Received before yesterday

New Eli Lilly Drug Retatrutide Brought Major Weight Loss in Trial

11 December 2025 at 16:09
The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.

ยฉ Mike Blake/Reuters

Eli Lilly company offices in San Diego. The company reported results of retatrutide, its next-generation weight-loss drug.
โŒ